Related Experiment Video
Updated: May 11, 2026

08:39
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Finding Consensus on Dialysis Access Stent-Graft Utilisation Strategies in Symptomatic Dysfunctional Arteriovenous
Gianmarco de Donato1,2, Jose Maria Abadal3, Paul Gibbs4
1Vascular Surgery, University of Siena, Siena, Italy.
Summary
European experts reached consensus on using stent-grafts for dysfunctional haemodialysis vascular access (VA). This guidance aims to standardize treatment strategies for improved patient outcomes.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Nephrology
Background:
- Treatment algorithms for dysfunctional haemodialysis vascular access (VA) lack standardization.
- The role of stent-grafts in managing symptomatic dysfunctional VA is not universally defined.
Purpose of the Study:
- To establish consensus among European experts on stent-graft strategies for symptomatic dysfunctional VA.
- To develop standardized recommendations for the use of stent-grafts in vascular access management.
Main Methods:
- A modified 3-round Delphi study involving 12 European experts from diverse specialties.
- Experts evaluated 57 statements on stent-graft utilization, patient factors, and specific anatomical challenges.
- Consensus was defined as ≥75% agreement, with a grading system applied to indicate agreement levels.
Main Results:
- Strong consensus (81% of statements) was achieved across multiple domains regarding stent-graft use.
- Expert panel consensus supported stent-graft application for graft-venous anastomosis, recurrent central venous stenosis, in-stent stenosis, and cannulation zone restenosis.
- High response stability and expert retention (100%) were observed throughout the Delphi process.
Conclusions:
- The Delphi consensus provides robust guidance for current stent-graft strategies in dysfunctional VA.
- Recommendations cover best practices for stent-graft utilization in various vascular access scenarios.
- This multidisciplinary expert-based consensus aims to improve the management of haemodialysis vascular access.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
